Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer

SIMPLE SUMMARY: Over 70% of breast cancer patients in the US have estrogen receptor (ER)-positive tumors. A better predictive biomarker of endocrine therapy would be useful to improve patient compliance. We found that estrogen response early score generated by a GSEA algorithm was significantly asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshi, Masanori, Tokumaru, Yoshihisa, Angarita, Fernando A., Yan, Li, Matsuyama, Ryusei, Endo, Itaru, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760577/
https://www.ncbi.nlm.nih.gov/pubmed/33260779
http://dx.doi.org/10.3390/cancers12123557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760577/
https://www.ncbi.nlm.nih.gov/pubmed/33260779
http://dx.doi.org/10.3390/cancers12123557

Ejemplares similares